These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 8304828
1. Inhibition of splenic macrophage tumor necrosis factor alpha secretion in vivo by antilipopolysaccharide monoclonal antibodies. Battafarano RJ, Burd RS, Kurrelmeyer KM, Ratz CA, Dunn DL. Arch Surg; 1994 Feb; 129(2):179-80. PubMed ID: 8304828 [Abstract] [Full Text] [Related]
11. Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice. Frasa H, Benaissa-Trouw B, Tavares L, van Kessel K, Poppelier M, Kraaijeveld K, Verhoef J. Infect Immun; 1996 Mar; 64(3):775-81. PubMed ID: 8641781 [Abstract] [Full Text] [Related]
14. In vivo Lipopolysaccharide Tolerance Recruits CD11b+ Macrophages to the Liver with Enhanced Bactericidal Activity and Low Tumor Necrosis Factor-Releasing Capability, Resulting in Drastic Resistance to Lethal Septicemia. Kinoshita M, Miyazaki H, Nakashima H, Nakashima M, Nishikawa M, Ishikiriyama T, Kato S, Iwaya K, Hiroi S, Shinomiya N, Seki S. J Innate Immun; 2017 Mar; 9(5):493-510. PubMed ID: 28675904 [Abstract] [Full Text] [Related]
15. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli. Pontes GN, Massironi SG, Arslanian C, Palmeira P, Carneiro-Sampaio MM, Nagao AT. Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122 [Abstract] [Full Text] [Related]